secwatch.observer — SEC 8-K summary
======================================

Issuer:     Z Squared Inc. (ZSQR)
CIK:        0001759186
Form:       8-K
Filed at:   2024-12-04T23:59:59+00:00
Accession:  0001683168-24-008519
Event type: m_and_a
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Coeptis Therapeutics signs binding LOI to acquire NexGenAI AI marketing platform
--------------------------------------------------------------------------------

- Binding letter of intent to acquire NexGenAI Affiliates Network, an AI-powered marketing and RPA platform.
- Platform targets biotech, pharmaceutical, and multi-level marketing industries for compliance and efficiency.
- Closing subject to preparation and execution of definitive documents; no material terms disclosed.
- Acquisition expands Coeptis beyond cell therapy into AI-driven marketing software solutions.
- CEO Dave Mehalick says integration will drive operational efficiency and growth opportunities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1759186/000168316824008519/0001683168-24-008519-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1759186/000168316824008519/coeptis_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-008519

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer